Efficacy of intravenous dexmedetomidine versus intraperitoneal dexmedetomidine in laparoscopic cholecystectomy – A prospective randomized double-blinded study

Background: Dexmedetomidine now has become one of the frequently used drugs as part of a multimodal analgesic regimen to provide improved pain control at all perioperative stages for laparoscopic surgeries. Aims and Objectives: In this prospective, double-blind, randomized, and control trial, we...

Full description

Bibliographic Details
Main Authors: Sumati Kandi, Laxmi Kanta Panigraghy, Harish chandra Dhamudia, Pradipta Kumar Patel, Panchanana Sethi
Format: Article
Language:English
Published: Manipal College of Medical Sciences, Pokhara 2022-08-01
Series:Asian Journal of Medical Sciences
Subjects:
Online Access:https://www.nepjol.info/index.php/AJMS/article/view/42565
_version_ 1818472285759078400
author Sumati Kandi
Laxmi Kanta Panigraghy
Harish chandra Dhamudia
Pradipta Kumar Patel
Panchanana Sethi
author_facet Sumati Kandi
Laxmi Kanta Panigraghy
Harish chandra Dhamudia
Pradipta Kumar Patel
Panchanana Sethi
author_sort Sumati Kandi
collection DOAJ
description Background: Dexmedetomidine now has become one of the frequently used drugs as part of a multimodal analgesic regimen to provide improved pain control at all perioperative stages for laparoscopic surgeries. Aims and Objectives: In this prospective, double-blind, randomized, and control trial, we compared the postoperative analgesic efficacy of intravenous (IV) dexmedetomidine and intraperitoneal (IP) dexmedetomidine in laparoscopic cholecystectomy. Materials and Methods: Sixty patients of the American Society of Anesthesiologists Grade I and II undergoing laparoscopic cholecystectomy were allocated into two groups. The patients in Group-IV had received 30 ml of 0.5 μg/kg Dexmedetomidine infusion intravenously plus 40 ml of Ropivacaine (30 mL of 0.5% Ropivacaine and 10 ml NS) intraperitoneally and in Group-IP received 30 ml NS intravenously and 40 ml of Ropivacaine plus Dexmedetomidine (30 mL of 0.5% Ropivacaine and 0.5 μg/kg Dexmedetomidine diluted in 10 ml NS) intraperitoneally after removal of the gallbladder. Patients were assessed during the first 24 h postoperatively for time to the first requirement of analgesia, total analgesic consumption, sedation, hemodynamics, side effects, and patient satisfaction. Results: Time to first request of analgesia (min) was longer (216.46±42.19 vs. 108.03±48.77) and total analgesic consumption (mg) was lower (92.50±32.26 vs 115.0±38.056) in Group-IV than in Group-IP. A significant difference was observed in visual analogue score in Group-IV at 1 h, 2 h, 4 h postoperatively and in the patient satisfaction score (P=0.024) in comparison to Group-IP. Conclusion: The postoperative analgesic effects and patient satisfaction, of low dose IV Dexmedetomidine plus IP instillation of Ropivacaine, are superior to low dose IP Dexmedetomidine added to Ropivacaine.
first_indexed 2024-04-14T04:04:57Z
format Article
id doaj.art-80b42793e73a4582b13948b5d67727c6
institution Directory Open Access Journal
issn 2467-9100
2091-0576
language English
last_indexed 2024-04-14T04:04:57Z
publishDate 2022-08-01
publisher Manipal College of Medical Sciences, Pokhara
record_format Article
series Asian Journal of Medical Sciences
spelling doaj.art-80b42793e73a4582b13948b5d67727c62022-12-22T02:13:24ZengManipal College of Medical Sciences, PokharaAsian Journal of Medical Sciences2467-91002091-05762022-08-011381926https://doi.org/10.3126/ajms.v13i8.42565Efficacy of intravenous dexmedetomidine versus intraperitoneal dexmedetomidine in laparoscopic cholecystectomy – A prospective randomized double-blinded studySumati Kandi 0https://orcid.org/0000-0002-4963-0359Laxmi Kanta Panigraghy 1Harish chandra Dhamudia 2https://orcid.org/0000-0001-5239-8573Pradipta Kumar Patel 3Panchanana Sethi 4Assistant Professor, Department of Anaesthesiology, Veer Surendra Sai Institute of Medical Science and Research, Sambalpur, Odisha, India Assistant Professor, Department of Anaesthesiology, Veer Surendra Sai Institute of Medical Science and Research, Sambalpur, Odisha, IndiaAssistant Professor, Department of General Surgery, Veer Surendra Sai Institute of Medical Science and Research, Sambalpur, Odisha, India Associate Professor, Department of Anaesthesiology, Veer Surendra Sai Institute of Medical Science and Research, Sambalpur, Odisha, IndiaJunior Resident, Department of Anaesthesiology, Veer Surendra Sai Institute of Medical Science and Research, Sambalpur, Odisha, IndiaBackground: Dexmedetomidine now has become one of the frequently used drugs as part of a multimodal analgesic regimen to provide improved pain control at all perioperative stages for laparoscopic surgeries. Aims and Objectives: In this prospective, double-blind, randomized, and control trial, we compared the postoperative analgesic efficacy of intravenous (IV) dexmedetomidine and intraperitoneal (IP) dexmedetomidine in laparoscopic cholecystectomy. Materials and Methods: Sixty patients of the American Society of Anesthesiologists Grade I and II undergoing laparoscopic cholecystectomy were allocated into two groups. The patients in Group-IV had received 30 ml of 0.5 μg/kg Dexmedetomidine infusion intravenously plus 40 ml of Ropivacaine (30 mL of 0.5% Ropivacaine and 10 ml NS) intraperitoneally and in Group-IP received 30 ml NS intravenously and 40 ml of Ropivacaine plus Dexmedetomidine (30 mL of 0.5% Ropivacaine and 0.5 μg/kg Dexmedetomidine diluted in 10 ml NS) intraperitoneally after removal of the gallbladder. Patients were assessed during the first 24 h postoperatively for time to the first requirement of analgesia, total analgesic consumption, sedation, hemodynamics, side effects, and patient satisfaction. Results: Time to first request of analgesia (min) was longer (216.46±42.19 vs. 108.03±48.77) and total analgesic consumption (mg) was lower (92.50±32.26 vs 115.0±38.056) in Group-IV than in Group-IP. A significant difference was observed in visual analogue score in Group-IV at 1 h, 2 h, 4 h postoperatively and in the patient satisfaction score (P=0.024) in comparison to Group-IP. Conclusion: The postoperative analgesic effects and patient satisfaction, of low dose IV Dexmedetomidine plus IP instillation of Ropivacaine, are superior to low dose IP Dexmedetomidine added to Ropivacaine.https://www.nepjol.info/index.php/AJMS/article/view/42565dexmedetomidine; intraperitoneal instillation; postoperative pain; ropivacaine
spellingShingle Sumati Kandi
Laxmi Kanta Panigraghy
Harish chandra Dhamudia
Pradipta Kumar Patel
Panchanana Sethi
Efficacy of intravenous dexmedetomidine versus intraperitoneal dexmedetomidine in laparoscopic cholecystectomy – A prospective randomized double-blinded study
Asian Journal of Medical Sciences
dexmedetomidine; intraperitoneal instillation; postoperative pain; ropivacaine
title Efficacy of intravenous dexmedetomidine versus intraperitoneal dexmedetomidine in laparoscopic cholecystectomy – A prospective randomized double-blinded study
title_full Efficacy of intravenous dexmedetomidine versus intraperitoneal dexmedetomidine in laparoscopic cholecystectomy – A prospective randomized double-blinded study
title_fullStr Efficacy of intravenous dexmedetomidine versus intraperitoneal dexmedetomidine in laparoscopic cholecystectomy – A prospective randomized double-blinded study
title_full_unstemmed Efficacy of intravenous dexmedetomidine versus intraperitoneal dexmedetomidine in laparoscopic cholecystectomy – A prospective randomized double-blinded study
title_short Efficacy of intravenous dexmedetomidine versus intraperitoneal dexmedetomidine in laparoscopic cholecystectomy – A prospective randomized double-blinded study
title_sort efficacy of intravenous dexmedetomidine versus intraperitoneal dexmedetomidine in laparoscopic cholecystectomy a prospective randomized double blinded study
topic dexmedetomidine; intraperitoneal instillation; postoperative pain; ropivacaine
url https://www.nepjol.info/index.php/AJMS/article/view/42565
work_keys_str_mv AT sumatikandi efficacyofintravenousdexmedetomidineversusintraperitonealdexmedetomidineinlaparoscopiccholecystectomyaprospectiverandomizeddoubleblindedstudy
AT laxmikantapanigraghy efficacyofintravenousdexmedetomidineversusintraperitonealdexmedetomidineinlaparoscopiccholecystectomyaprospectiverandomizeddoubleblindedstudy
AT harishchandradhamudia efficacyofintravenousdexmedetomidineversusintraperitonealdexmedetomidineinlaparoscopiccholecystectomyaprospectiverandomizeddoubleblindedstudy
AT pradiptakumarpatel efficacyofintravenousdexmedetomidineversusintraperitonealdexmedetomidineinlaparoscopiccholecystectomyaprospectiverandomizeddoubleblindedstudy
AT panchananasethi efficacyofintravenousdexmedetomidineversusintraperitonealdexmedetomidineinlaparoscopiccholecystectomyaprospectiverandomizeddoubleblindedstudy